Free Trial

Ambev S.A. (NYSE:ABEV) Given Average Recommendation of "Hold" by Brokerages

Ambev logo with Consumer Staples background

Shares of Ambev S.A. (NYSE:ABEV - Get Free Report) have been given a consensus recommendation of "Hold" by the six analysts that are presently covering the firm, MarketBeat reports. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $2.75.

A number of analysts recently issued reports on the company. UBS Group lowered their price target on Ambev from $3.20 to $2.90 and set a "buy" rating for the company in a research report on Wednesday, July 31st. StockNews.com initiated coverage on shares of Ambev in a report on Friday, October 18th. They set a "buy" rating on the stock.

Get Our Latest Research Report on Ambev

Institutional Trading of Ambev

A number of hedge funds have recently bought and sold shares of the stock. Renaissance Technologies LLC raised its position in shares of Ambev by 27.7% in the 2nd quarter. Renaissance Technologies LLC now owns 34,133,000 shares of the company's stock worth $69,973,000 after acquiring an additional 7,412,395 shares in the last quarter. Seafarer Capital Partners LLC increased its position in shares of Ambev by 6.3% during the third quarter. Seafarer Capital Partners LLC now owns 30,069,000 shares of the company's stock worth $73,368,000 after purchasing an additional 1,770,000 shares in the last quarter. Pzena Investment Management LLC lifted its holdings in shares of Ambev by 29.4% during the 2nd quarter. Pzena Investment Management LLC now owns 18,385,312 shares of the company's stock valued at $37,690,000 after purchasing an additional 4,179,978 shares during the last quarter. Brandes Investment Partners LP grew its stake in Ambev by 23.9% during the 2nd quarter. Brandes Investment Partners LP now owns 15,456,266 shares of the company's stock worth $32,024,000 after buying an additional 2,982,621 shares during the last quarter. Finally, Kiltearn Partners LLP increased its position in Ambev by 43.3% during the 2nd quarter. Kiltearn Partners LLP now owns 14,575,900 shares of the company's stock valued at $29,881,000 after buying an additional 4,407,800 shares in the last quarter. Hedge funds and other institutional investors own 8.13% of the company's stock.

Ambev Price Performance

Shares of NYSE ABEV traded down $0.01 during mid-day trading on Wednesday, hitting $2.21. 25,194,520 shares of the company's stock traded hands, compared to its average volume of 18,845,586. The company's 50-day moving average is $2.32 and its two-hundred day moving average is $2.26. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.20 and a quick ratio of 0.89. Ambev has a 1 year low of $2.01 and a 1 year high of $3.00. The company has a market capitalization of $34.82 billion, a P/E ratio of 12.33, a PEG ratio of 5.11 and a beta of 1.06.

Ambev Company Profile

(Get Free Report

Ambev SA, through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt and food, other alcoholic beverages, and non-alcoholic and non-carbonated products in Brazil, Central America and Caribbean, Latin America South, and Canada. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe, Hoegaarden, Balboa ICE, Balboa, Atlas Golden Light, Atlas, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Bud 66, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands.

Read More

Analyst Recommendations for Ambev (NYSE:ABEV)

Should you invest $1,000 in Ambev right now?

Before you consider Ambev, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambev wasn't on the list.

While Ambev currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Whitestone REIT is Outperforming in 2024: 35% Growth & Monthly Dividends
Why SoundHound Stock Dip Could Mean Big Gains for 2025 Investors
Nintendo Stock: Buy Before the 2025 Switch Platform Hits!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines